SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE |
Basic
and diluted net loss per share for each of the periods presented are calculated as follows:
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE
| |
2023 | | |
2024 | | |
2024 | |
| |
For the fiscal years ended
March 31, | | |
For the nine months ended
December 31, | |
| |
2023 | | |
2024 | | |
2024 | |
| |
RMB | | |
RMB | | |
RMB | |
| |
| | |
| | |
| |
Basic net loss per share | |
| | | |
| | | |
| | |
Numerator: | |
| | | |
| | | |
| | |
Net loss attributable to Uxin Limited | |
| (137,157 | ) | |
| (372,387 | ) | |
| (204,312 | ) |
Deemed dividend to preferred shareholders due to triggering of a down round feature | |
| (755,635 | ) | |
| (2,060,254 | ) | |
| - | |
Net loss attributable to ordinary shareholders | |
| (892,792 | ) | |
| (2,432,641 | ) | |
| (204,312 | ) |
| |
| | | |
| | | |
| | |
Denominator: | |
| | | |
| | | |
| | |
Number of ordinary shares outstanding at the beginning of the period | |
| 1,186,854,720 | | |
| 1,410,826,415 | | |
| 56,381,481,399 | |
Weighted average number of ordinary shares issued | |
| 151,885,463 | | |
| 754,367,970 | | |
| 6,137,059 | |
Weighted average number of vested penny options | |
| 5,796,382 | | |
| 20,169,250 | | |
| 29,241,834 | |
Weighted average number of unissued shares relating to the Performance Awards (Note 18) | |
| - | | |
| - | | |
| 327,882,355 | |
Weighted average number of ordinary shares outstanding - basic | |
| 1,344,536,565 | | |
| 2,185,363,635 | | |
| 56,744,742,647 | |
| |
| | | |
| | | |
| | |
Net loss per share attributable to ordinary shareholders, basic | |
| (0.66 | ) | |
| (1.11 | ) | |
| (0.00 | ) |
| |
| | | |
| | | |
| | |
Diluted net loss per share | |
| | | |
| | | |
| | |
Numerator: | |
| | | |
| | | |
| | |
Diluted net loss attributable to ordinary shareholders | |
| (892,792 | ) | |
| (2,432,641 | ) | |
| (204,312 | ) |
UXIN LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All
amounts in thousands, except for share and per share data, unless otherwise noted)
21.
NET LOSS PER SHARE (CONTINUED)
| |
For the fiscal years ended March 31, | | |
For the nine months ended
December 31, | |
| |
2023 | | |
2024 | | |
2024 | |
| |
RMB | | |
RMB | | |
RMB | |
| |
| | |
| | |
| |
Denominator: | |
| | | |
| | | |
| | |
Weighted average number of ordinary shares outstanding – diluted | |
| 1,344,536,565 | | |
| 2,185,363,635 | | |
| 56,744,742,647 | |
| |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | |
Net loss per share attributable to ordinary shareholders, diluted | |
| (0.66 | ) | |
| (1.11 | ) | |
| (0.00 | ) |
|
SCHEDULE OF POTENTIAL ORDINARY SHARES THAT ARE ANTI-DILUTIVE AND EXCLUDED FROM THE CALCULATION OF DILUTED NET LOSS PER SHARE |
SCHEDULE OF POTENTIAL ORDINARY SHARES THAT ARE ANTI-DILUTIVE AND EXCLUDED FROM THE CALCULATION OF DILUTED NET LOSS PER SHARE
| |
2023 | | |
2024 | | |
2024 | |
| |
For
the fiscal years ended March 31, | | |
For the nine months ended
December 31, | |
| |
2023 | | |
2024 | | |
2024 | |
| |
| | |
| | |
| |
Unissued shares relating to the Performance Awards (Note 18) | |
| - | | |
| - | | |
| 594,838,632 | |
Forward contract | |
| - | | |
| - | | |
| 216,847,736 | |
Senior convertible preferred shares | |
| 912,262,870 | | |
| 1,288,858,108 | | |
| - | |
Outstanding weighted average share options | |
| 11,114,657 | | |
| 13,605,459 | | |
| 9,937,549 | |
Total | |
| 923,377,527 | | |
| 1,302,463,567 | | |
| 821,623,917 | |
Anti-dilutive securities excluded from the calculation of diluted net loss per share | |
| 923,377,527 | | |
| 1,302,463,567 | | |
| 821,623,917 | |
|